PENTAMETHYLMELAMINE (PMM): PHASE I CLINICAL AND PHARMACOKINETIC STUDIES = PENTAMETHYLMELAMINE: ETUDE CLINIQUE PHASE I ET PHARMACOCINETIQUEMUINDI JRF; NEWELL DR; SMITH IE et al.1983; BRITISH JOURNAL OF CANCER; ISSN 0007-0920; GBR; DA. 1983; VOL. 47; NO 1; PP. 27-33; ABS. ENG; BIBL. 26 REF.; GRAPHArticle

A PHASE I AND CLINICAL PHARMACOLOGY STUDY OF INTRAVENOUSLY ADMINISTERED CARMINOMYCIN IN CANCER PATIENTS IN THE UNITED STATESCOMIS RL; ISSELL BF; PITTMAN K et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2944-2948; BIBL. 15 REF.Article

PHASE I TRIAL OF INDICINE-N-OXIDE ON TWO DOSE SCHEDULES = ESSAI PHASE I DE L'INDICINE-N-OXYDE SELON DEUX PROTOCOLES DIFFERENTSTAYLOR S; BELT RJ; HAAS CD et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 11; PP. 1988-1991; ABS. ENG; BIBL. 4 REF.; GRAPHArticle

FINAL REPORT ON THE UNITED STATES PHASE 1 CLINICAL TRIAL OF THE HYPOXIC CELL RADIOSENSITIZER, MISONIDAZOLE (R0-07-0582; NSC#261037)PHILLIPS TL; WASSERMAN TH; JOHNSON RJ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 8; PP. 1697-1704; BIBL. 15 REF.Article

INITIAL CLINICAL EVALUATION OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD-32), AN ADRIAMYCIN ANALOGBLUM RH; GARNICK MB; ISRAEL M et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 919-923; BIBL. 20 REF.Article

PHASE I STUDY OF L-ALANOSINE (NSC 15353) = ETUDE PHASE I DE LA L-ALANOSINE (NSC 15353)GOLDSMITH MA; OHNUMA T; SPIGELMAN M et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 3; PP. 378-380; ABS. ENG; BIBL. 8 REF.; GRAPHArticle

EARLY TUMOR AND LEUKEMIA RESPONSE TO ALKYL-LYSOPHOSPHOLIPIDS IN A PHASE I STUDYBERDEL WE; SCHLEHE H; FINK U et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 10; PP. 2011-2015; BIBL. 16 REF.Article

PHARMACOKINETICS OF VINCRISTINE INFUSIONJACKSON DV JR; SAGAR SETHI V; SPURR CL et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1043-1048; BIBL. 15 REF.Article

PHASE I CLINICAL TRIAL WITH AMETANTRONE (NSC-287513)PICCART M; ROZENCWEIG M; ABELE R et al.1981; EUR. J. CANCER CLIN. ONCOL.; GBR; DA. 1981; VOL. 17; NO 7; PP. 775-779; BIBL. 9 REF.Article

METHYL-GAG IN PATIENTS WITH MALIGNANT NEOPLASMS: A PHASE 1 REEVALUATIONHART RD; OHNUMA T; HOLLAND JF et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 65-71; BIBL. 21 REF.Article

PHASE 1 STUDY OF L-ALANOSINE USING A DAILY X3 SCHEDULEDOSIK GM; STEWART D; VALDIVIESO M et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 73-76; BIBL. 13 REF.Article

PHASE I CLINICAL STUDY WITH 5'-DEOXY-5-FLUOROURIDINE, A NEW FLUOROPYRIMIDINE DERIVATIVEABELE R; ALBERTO P; SEEMATTER RJ et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 6; PP. 1307-1313; BIBL. 15 REF.Article

PHASE I EVALUATION OF CHLOROZOTOCIN: SINGLE DOSE EVERY SIX WEEKSTAYLOR S; BELT RJ; HAAS CD et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 11; PP. 2365-2368; BIBL. 7 REF.Article

PROBLEMS OF CLINICAL PHARMACOLOGY IN THERAPEUTIC RESEARCH. I. INTERNATIONAL SYMPOSIUM ON CLINICAL PHARMACOLOGY. 14. PROCEEDINGS; TOKYO; 1976.1977; ADV. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 13; PP. (432P.); BIBL. DISSEM.; ISBN 3541701137Conference Paper

WHATEVER HAPPENED TO NSC. AN ANALYSIS OF CLINICAL RESULTS OF DISCONTINUED ANTICANCER AGENTS.VON HOFF DD; ROZENCWEIG M; SOPER WT et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 5; PP. 759-768; BIBL. 4 P.Article

PHASE I EVALUATION OF PEPLOMYCIN WITH SPECIAL REFERENCE TO PULMONARY TOXICITY = ETUDE PHASE I DE LA PEPLOMYCINE EN PARTICULIER DE LA TOXICITE PULMONAIRESORENSEN PG; RORTH M; HANSEN HH et al.1983; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1983; VOL. 19; NO 3; PP. 319-325; ABS. ENG; BIBL. 16 REF.; GRAPHArticle

PHASE 1 TRIAL OF SPIROGERMANIUM GIVEN BY INFUSION IN A MULTIPLE-DOSE SCHEDULEBUDMAN DR; SCHULMAN P; VINCIGUERRA V et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 173-175; BIBL. 6 REF.Article

A MULTIPLE-DOSE PHASE I TRIAL OF RECOMBINANT LEUKOCYTE A INTERFERON IN CANCER PATIENTSSHERWIN SA; KNOST JA; FEIN S et al.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 248; NO 19; PP. 2461-2466; BIBL. 20 REF.Article

MULTIPLE-DOSE PHASE I TRIALS - NORMAL VOLUNTEERS OR PATIENTS. ONE VIEWPOINTWEISSMAN L.1981; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1981; VOL. 21; NO 10; PP. 385-387; BIBL. 4 REF.Article

90-Days mortality rate in patients treated within the context of a phase-I trial : How should we identify patients who should not go on trial?ARKENAU, Hendrik-Tobias; OLMOS, David; JOO ERN ANG et al.European journal of cancer (1990). 2008, Vol 44, Num 11, pp 1536-1540, issn 0959-8049, 5 p.Article

Clinical outcome and prognostic factors for patients treated within the context of a phase I study : the Royal Marsden Hospital experienceARKENAU, H-T; OLMOS, D; ANG, J. E et al.British journal of cancer. 2008, Vol 98, Num 6, pp 1029-1033, issn 0007-0920, 5 p.Article

Presentation and subsequent publication rates of phase I oncology clinical trialsCAMACHO, Luis H; BACIK, Jennifer; CHEUNG, Alexander et al.Cancer. 2005, Vol 104, Num 7, pp 1497-1504, issn 0008-543X, 8 p.Article

PHASE I TRIAL OF MITOXANTRONE BY 24-HOUR CONTINUOUS INFUSION = ESSAI PHASE I DE MITOXANTRONE EN PERFUSION CONTINUE DE 24 HEURESANDERSON KC; GARNICK MB; MESHAD MW et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 435-438; ABS. ENG; BIBL. 4 REF.; GRAPHArticle

PHASE-I STUDY OF ALPHA -1,3,5-TRIGLYCIDIL-S-TRIAZINETRIONE (NSC 296934)DOMBERNOWSKY P; LUND B; HANSEN HH et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 11; NO 1; PP. 59-61; BIBL. 8 REF.Article

PHARMACOKINETICS OF 13-CIS-RETINOIC ACID IN PATIENTS WITH ADVANCED CANCERGOODMAN GE; EINSPAHR JG; ALBERTS DS et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 5; PP. 2087-2091; BIBL. 16 REF.Article